Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
Eyes are the most important part of our sensory organs. They bring us the feeling of being and belonging. Whatever is done to keep them vivid is exceptionably low. A revision of the natural ways to improve our vision and an insight into the latest interventions for their prime care will help us better understand the different eye disorders spreading geographically and how we ignore the ever alarming risks UV and Infrared radiation pose to our precious little eyes. With the latest innovations in the field of ophthalmology and encouraging the stem cell research to research to restore any eyesight lost due to any such unnatural conditions paves novel ways to treat the eye disorders. An induction into current advancements available for eye care like eye drops, contact lenses and implantable contact lenses and Ophthalmic- Plastic & reconstructive Surgery. Hereby enabling the ways the patients can overcome eye sight related problems. In conclusion, let us discuss and expand our knowledge field’s boundaries in the already known and latest technologies in the fields of visual acuity charts, visual neuroscience, refractive error and physiological optics. Views about vision in clinical and molecular spheres, can help try and improve conditions prevalent in refractive error and use them in laser ophthalmology, artificial vision and ecology of color to perfect biomedical optics and ophthalmic lasers, binocular vision correction and in general – in vision therapy.
Importance and Scope:
The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Changing trends in diet and lifestyle as well as increased longevity are growing the market for ophthalmological treatments: the global ophthalmic device market is expected to reach $28 billion by 2016 exhibiting a 2.5% compound annual growth rate from 2009 to 2016, according to GBI Research. Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
The ophthalmology drugs market is classified based on the type of drugs; treatment based drugs, over the counter drugs and ocular anesthetics. Ocular anesthetics are administered by surgeons during surgery and cannot be bought by individuals. The treatment based drugs are provided based on the diagnosed conditions and are classified as dry eye drugs, retinal disorder drugs, anti-allergy/inflammatory/infective drugs and anti-glaucoma drugs. Over the counter drugs can be procured without any need of a prescription. This report analyses drugs and devices in the ophthalmology market along with its sub-segments for their revenues, key growth drivers and opportunities.
“The worldwide ophthalmic products market exceeds $22 billion (US) and is growing at more than 10% per year. Without the inclusion of consumer eye care products, the ophthalmic products market is roughly a $17 billion market.” Rising of demand for ophthalmic devices and expanding healthcare coverage in emerging economies will increase sales to 2024.The medical device market of Europe is mainly comprised of medical equipment such as consumables, orthopaedic devices, dental devices, respiratory devices, and ophthalmic devices which are manufactured in Germany, France, the UK, Italy and Spain. The demand for medical devices has been growing owing to a mounting awareness for early diagnosis and treatment of countless disease states in European countries. The key countries that have contributed significantly to the Europe medical devices market during 2008-2013 include Germany, UK, Spain and France. Germany is one of the major European markets and it has been observed that the country contributes immensely to the exports of medical devices. The overall medical devices market in Europe is projected to reach EUR Smillion in 2018, augmenting at a CAGR of 3.9% during 2013-2018.